PillRx only · Capsule · Oral
Lisdexamfetamine
Lisdexamfetamine Dimesylate
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US19 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers3 labelers
Packages19
DEA / ScheduleCII
US acquisition costNADAC · per unit
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$2.906
Latest avg · Jun 17, 2026
-10%
Since Dec 17, 2025
3
Active US suppliers
68%
Top-2 supplier share*
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Mylan Pharmaceuticals Inc. | unknown | 7 | SUPPLYING |
| AvKARE | unknown | 6 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 6 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.